Thanks to all who joined us for a memorable evening celebrating NNECOS!

As we look back at the milestones in NNECOS’ 30-year history, we also remember the people. We honor the memory of friend and long-time NNECOS leader, Dr. Steven Grunberg.

Enjoy this wonderful interview with 3 of NNECOS' founding members!

Please read this special message to our community.

Latest FDA Approvals

• Nov 17 - FDA approves pembrolizumab for adjuvant treatment of renal cell carcinoma
• Oct 29 - FDA approves asciminib for Philadelphia chromosome-positive chronic myeloid leukemia
• Oct 15 - FDA approves atezolizumab as adjuvant treatment for non-small cell lung cancer
• Oct 13 - FDA approves pembrolizumab combination for the first-line treatment of cervical cancer
• Oct 12 - FDA approves abemaciclib with endocrine therapy for early breast cancer

Package/Label Updates

• Oct 1 - J-code J9247 for Pepaxto® (melphalan flufenamide) injection, 1mg
• Oct 1 - J-Code J1448 for COSELA™ (trilaciclib)

Other Updates

Oct 7 - FDA recognizes Memorial Sloan-Kettering database of molecular tumor marker information

Do you have an idea, suggestion, or other feedback you'd like to share? Comment, concern or compliment? Reach out and

Share with NNECOS.

We'd love to hear from you! 

ASCO Survey on COVID in Oncology Registry

The aim is to help the cancer community learn more about the patterns of symptoms & severity of COVID among patients with cancer, as well as the impact on delivery of cancer care & patient outcomes. Periodic reports will deliver real-time information to the oncology community.

• ASCO Registry FAQs
• Enroll Your Practice
• Questions

ASCO COVID Resource Page

COVID Info & Resources including a Fact Sheet on EUA of BAmlanivimab